Literature DB >> 30504743

Value of ATRIA risk score and gender in predicting adverse events in patients with myocardial infarction.

Can Ramazan Öncel1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30504743      PMCID: PMC6287440          DOI: 10.14744/AnatolJCardiol.2018.25483

Source DB:  PubMed          Journal:  Anatol J Cardiol        ISSN: 2149-2263            Impact factor:   1.596


× No keyword cloud information.
To the Editor, I have read the article by Çetinkal et al. (1) entitled “Comparative performance of AnTicoagulation and Risk factors In Atrial fibrillation and Global Registry of Acute Coronary Events risk scores in predicting long-term adverse events in patients with acute myocardial infarction” with great interest, which was published in Anatol J Cardiol 2018; 20: 77-84. In their study, the authors divided 1627 patients with acute myocardial infarction into three risk groups according to ATRIA risk score: ATRIA 0, ATRIA 1-2, and ATRIA >3. They reported that ATRIA risk score >3 was found to be an independent predictor of major adverse cardiac events in this group. This is a well-written study, and I would like to draw attention to the gender-related differences that can affect the results of the present study. Çetinkal et al. (1) reported that ATRIA risk score >3 had a predictive value for major adverse cardiac events in patients with acute myocardial infarction. As female gender represents 1 point in ATRIA risk score, I think that gender becomes a more important factor in this study population. In the present study, none of the patients in ATRIA 0 group and 18.7% of the patients in ATRIA 1-2 group were females, while 38.1% of the patients in ATRIA >3 group were females. It has been shown that female patients have a higher risk for poor outcomes in acute myocardial infarction than male patients (2). Moreover, it has been described that psychological pathologies and social problems like depression, anxiety, and anger are possible risk factors associated with poor outcomes in female patients with cardiovascular diseases (3). It has also been demonstrated that pre-conditioning and pre-infarction angina is related with decreased left ventricular systolic function in males with acute coronary syndrome compared with that in females (4). In conclusion, because 38.1% of the study population in ATRIA >3 group are females, to verify whether the ATRIA risk score provides an additional risk stratification beyond that provided by conventional risk scores, gender-related factors should be taken into consideration in the present study.
  4 in total

1.  The impact of gender difference on the effects of preinfarction angina on microvascular damage with reperfused myocardial infarction.

Authors:  Shinobu Hosokawa; Yoshikazu Hiasa; Naotsugu Murakami; Yohei Tobbeto; Takafumi Nakagawa; Pomin Chen; Shin-Ichiro Miyazaki; Riyo Ogura; Keitaro Mahara; Hitoshi Miyajima; Kenichiro Yuba; Takefumi Takahashi; Koichi Kishi; Ryuji Ohtani
Journal:  Clin Cardiol       Date:  2010-07       Impact factor: 2.882

2.  Prognostic value of depression, anxiety, and anger in hospitalized cardiovascular disease patients for predicting adverse cardiac outcomes.

Authors:  Shunichi Nakamura; Koji Kato; Asuka Yoshida; Nagaharu Fukuma; Yasuyuki Okumura; Hiroto Ito; Kyoichi Mizuno
Journal:  Am J Cardiol       Date:  2013-02-20       Impact factor: 2.778

3.  Transradial versus transfemoral access for female patients who underwent primary PCI in STEMI: Two years follow-up data from acute STEMI interventional registry.

Authors:  Sasko Kedev; Renan Sukmawan; Oliver Kalpak; Surya Dharma; Slobodan Antov; Jorgo Kostov; Hristo Pejkov; Igor Spiroski
Journal:  Int J Cardiol       Date:  2016-06-28       Impact factor: 4.164

4.  Comparative performance of AnTicoagulation and Risk factors In Atrial fibrillation and Global Registry of Acute Coronary Events risk scores in predicting long-term adverse events in patients with acute myocardial infarction.

Authors:  Gökhan Çetinkal; Cüneyt Koçaş; Betül Balaban Koçaş; Şükrü Arslan; Okay Abacı; Osman Şükrü Karaca; Yalçın Dalgıç; Özgür Selim Ser; Kudret Keskin; Ahmet Yıldız; Sait Mesut Doğan
Journal:  Anatol J Cardiol       Date:  2018-08       Impact factor: 1.596

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.